Skip to main content
. 2019 Jul 2;116(29):14573–14582. doi: 10.1073/pnas.1908547116

Fig. 7.

Fig. 7.

Model depicting the mechanism by which selective targeting of PARP-2 attenuates AR signaling and inhibits PCa growth. PARP-2 enhances AR transcriptional activity via physically interacting with the pioneer factor FOXA1. Selective PARP-2 inhibitor UPF-1069 blocks this interaction, diminishes the genomic occupancies of FOXA1 and H3K27Ac at AR binding sites, and, thereby, inhibits AR-mediated gene expression and PCa growth.